[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5358 Introduced in House (IH)]
112th CONGRESS
2d Session
H. R. 5358
To suspend temporarily the duty on placebos to be used in clinical
trials for the drug ASP0777.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
May 7, 2012
Mr. Dold introduced the following bill; which was referred to the
Committee on Ways and Means
_______________________________________________________________________
A BILL
To suspend temporarily the duty on placebos to be used in clinical
trials for the drug ASP0777.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. PLACEBOS TO BE USED IN CLINICAL TRIALS FOR THE DRUG ASP0777.
(a) In General.--Subchapter II of chapter 99 of the Harmonized
Tariff Schedule of the United States is amended by inserting in
numerical sequence the following new heading:
`` 9902.01.00 Placebos, composed Free No change No change On or before ''.
of D-mannitol, 12/31/2015
sodium starch
glycolate, and
magnesium
stearate, to be
used in clinical
trials for the
drug ASP0777
(provided for in
subheading
2106.90.99)......
(b) Effective Date.--The amendment made by subsection (a) applies
to goods entered, or withdrawn from warehouse for consumption, on or
after the 15th day after the date of the enactment of this Act.
<all>
Introduced in House
Introduced in House
Referred to the House Committee on Ways and Means.
Referred to the Subcommittee on Trade.
Llama 3.2 · runs locally in your browser
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line